News
06-02-2008, 03:21 PM
BiPar Sciences, Inc. today announced the results of first-in-human clinical studies of its lead product, BSI-201, in patients with solid tumors.
More... (http://www.news-medical.net/?id=38814)
More... (http://www.news-medical.net/?id=38814)